{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:36:15Z","timestamp":1791282975567,"version":"4.1.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>DNA methylation at cytosine bases (5-methylcytosine, 5mC) is a heritable epigenetic mark regulating gene expression. While enzymes that metabolize 5mC are well-characterized, endogenous signaling molecules that regulate DNA methylation machinery have not been described. We report that physiological nitric oxide (NO) concentrations reversibly inhibit the DNA demethylases TET and ALKBH2 by binding to the mononuclear non-heme iron atom forming a dinitrosyliron complex (DNIC) and preventing cosubstrates from binding. In cancer cells treated with exogenous NO, or endogenously synthesizing NO, 5mC and 5-hydroxymethylcytosine (5hmC) increase, with no changes in DNA methyltransferase activity. 5mC is also significantly increased in NO-producing patient-derived xenograft tumors from mice. Genome-wide methylome analysis of cells chronically treated with NO (10 days) shows enrichment of 5mC and 5hmC at gene-regulatory loci, correlating with altered expression of NO-regulated tumor-associated genes. Regulation of DNA methylation is distinctly different from canonical NO signaling and represents a unique epigenetic role for NO.<\/jats:p>","DOI":"10.1038\/s41467-025-56928-1","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T09:32:14Z","timestamp":1739871134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Nitric oxide inhibits ten-eleven translocation DNA demethylases to regulate 5mC and 5hmC across the genome"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4957-2387","authenticated-orcid":false,"given":"Marianne B.","family":"Palczewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Petraitis","family":"Kuschman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3100-0746","authenticated-orcid":false,"given":"Brian M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4151-9154","authenticated-orcid":false,"given":"Venkatesan","family":"Kathiresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7310-2935","authenticated-orcid":false,"given":"Eric T.","family":"Kool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5776-2530","authenticated-orcid":false,"given":"William R.","family":"Montfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydolun","family":"Petenkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Chronis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Cundari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Sappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabirul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1112-5111","authenticated-orcid":false,"given":"Daniel W.","family":"McVicar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7473-6104","authenticated-orcid":false,"given":"Yu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoud","family":"Meerzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0657-0288","authenticated-orcid":false,"given":"Michael","family":"Sierk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1252-0786","authenticated-orcid":false,"given":"Douglas D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"56928_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrg3032","volume":"12","author":"AC Ferguson-Smith","year":"2011","unstructured":"Ferguson-Smith, A. C. Genomic imprinting: the emergence of an epigenetic paradigm. Nat. Rev. Genet. 12, 565\u2013575 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"56928_CR2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.febslet.2009.04.012","volume":"583","author":"RS Illingworth","year":"2009","unstructured":"Illingworth, R. S. & Bird, A. P. CpG islands-\u2018a rough guide\u2019. FEBS Lett. 583, 1713\u20131720 (2009).","journal-title":"FEBS Lett."},{"key":"56928_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41580-021-00438-7","volume":"23","author":"A Loda","year":"2022","unstructured":"Loda, A., Collombet, S. & Heard, E. Gene regulation in time and space during X-chromosome inactivation. Nat. Rev. Mol. Cell Biol. 23, 231\u2013249 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"56928_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484\u2013492 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"56928_CR5","doi-asserted-by":"crossref","unstructured":"Yin, Y. et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science 356, eaaj2239 (2017).","DOI":"10.1126\/science.aaj2239"},{"key":"56928_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0168-9525(98)01636-9","volume":"15","author":"PA Jones","year":"1999","unstructured":"Jones, P. A. The DNA methylation paradox. Trends Genet. 15, 34\u201337 (1999).","journal-title":"Trends Genet."},{"key":"56928_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930\u2013935 (2009).","journal-title":"Science"},{"key":"56928_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r54","volume":"12","author":"H Stroud","year":"2011","unstructured":"Stroud, H., Feng, S., Morey Kinney, S., Pradhan, S. & Jacobsen, S. E. 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol. 12, R54 (2011).","journal-title":"Genome Biol."},{"key":"56928_CR9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nature14482","volume":"523","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Molecular basis for 5-carboxycytosine recognition by RNA polymerase II elongation complex. Nature 523, 621\u2013625 (2015).","journal-title":"Nature"},{"key":"56928_CR10","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/sj.emboj.7601109","volume":"25","author":"J Ringvoll","year":"2006","unstructured":"Ringvoll, J. et al. Repair deficient mice reveal mABH2 as the primary oxidative demethylase for repairing 1meA and 3meC lesions in DNA. EMBO J. 25, 2189\u20132198 (2006).","journal-title":"EMBO J."},{"key":"56928_CR11","doi-asserted-by":"publisher","first-page":"14051","DOI":"10.1073\/pnas.0403489101","volume":"101","author":"JC Delaney","year":"2004","unstructured":"Delaney, J. C. & Essigmann, J. M. Mutagenesis, genotoxicity, and repair of 1-methyladenine, 3-alkylcytosines, 1-methylguanine, and 3-methylthymine in alkB Escherichia coli. Proc. Natl Acad. Sci. USA 101, 14051\u201314056 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56928_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2015.06.002","volume":"87","author":"DD Thomas","year":"2015","unstructured":"Thomas, D. D. et al. Signaling and stress: the redox landscape in NOS2 biology. Free Radic. Biol. Med. 87, 204\u2013225 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"56928_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1073\/pnas.98.1.355","volume":"98","author":"DD Thomas","year":"2001","unstructured":"Thomas, D. D., Liu, X., Kantrow, S. P. & Lancaster, J. R. Jr. The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc. Natl Acad. Sci. USA 98, 355\u2013360 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56928_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.redox.2012.11.002","volume":"1","author":"JR Hickok","year":"2013","unstructured":"Hickok, J. R., Vasudevan, D., Jablonski, K. & Thomas, D. D. Oxygen dependence of nitric oxide-mediated signaling. Redox Biol. 1, 203\u2013209 (2013).","journal-title":"Redox Biol."},{"key":"56928_CR15","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.freeradbiomed.2011.06.030","volume":"51","author":"JR Hickok","year":"2011","unstructured":"Hickok, J. R. et al. Dinitrosyliron complexes are the most abundant nitric oxide-derived cellular adduct: biological parameters of assembly and disappearance. Free Radic. Biol. Med. 51, 1558\u20131566 (2011).","journal-title":"Free Radic. Biol. Med."},{"key":"56928_CR16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1089\/ars.2012.4543","volume":"17","author":"JR Hickok","year":"2012","unstructured":"Hickok, J. R., Vasudevan, D., Thatcher, G. R. & Thomas, D. D. Is S-nitrosocysteine a true surrogate for nitric oxide? Antioxid. Redox Signal 17, 962\u2013968 (2012).","journal-title":"Antioxid. Redox Signal"},{"key":"56928_CR17","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1074\/jbc.R111.285742","volume":"287","author":"DT Hess","year":"2012","unstructured":"Hess, D. T. & Stamler, J. S. Regulation by S-nitrosylation of protein post-translational modification. J. Biol. Chem. 287, 4411\u20134418 (2012).","journal-title":"J. Biol. Chem."},{"key":"56928_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2174\/138161210790232149","volume":"16","author":"JR Hickok","year":"2010","unstructured":"Hickok, J. R. & Thomas, D. D. Nitric oxide and cancer therapy: the emperor has NO clothes. Curr. Pharm. Des. 16, 381\u2013391 (2010).","journal-title":"Curr. Pharm. Des."},{"key":"56928_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/B978-0-12-800254-4.00011-8","volume":"96","author":"D Vasudevan","year":"2014","unstructured":"Vasudevan, D. & Thomas, D. D. Insights into the diverse effects of nitric oxide on tumor biology. Vitam. Horm. 96, 265\u2013298 (2014).","journal-title":"Vitam. Horm."},{"key":"56928_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejca.2004.07.010","volume":"41","author":"S Loibl","year":"2005","unstructured":"Loibl, S. et al. The role of early expression of inducible nitric oxide synthase in human breast cancer. Eur. J. Cancer 41, 265\u2013271 (2005).","journal-title":"Eur. J. Cancer"},{"key":"56928_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00418-001-0356-0","volume":"117","author":"B De Paepe","year":"2002","unstructured":"De Paepe, B., Verstraeten, V. M., De Potter, C. R. & Bullock, G. R. Increased angiotensin II type-2 receptor density in hyperplasia, DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression. Histochem. Cell Biol. 117, 13\u201319 (2002).","journal-title":"Histochem. Cell Biol."},{"key":"56928_CR22","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1073\/pnas.1401799111","volume":"111","author":"JL Heinecke","year":"2014","unstructured":"Heinecke, J. L. et al. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression. Proc. Natl Acad. Sci. USA 111, 6323\u20136328 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56928_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3319","volume":"14","author":"CH Switzer","year":"2012","unstructured":"Switzer, C. H. et al. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer. Breast Cancer Res. 14, R125 (2012).","journal-title":"Breast Cancer Res."},{"key":"56928_CR24","doi-asserted-by":"publisher","first-page":"e44081","DOI":"10.1371\/journal.pone.0044081","volume":"7","author":"LA Ridnour","year":"2012","unstructured":"Ridnour, L. A. et al. Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation. PLoS One 7, e44081 (2012).","journal-title":"PLoS One"},{"key":"56928_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1615\/ForumImmunDisTher.2012006108","volume":"3","author":"CH Switzer","year":"2012","unstructured":"Switzer, C. H. et al. S-nitrosation mediates multiple pathways that lead to tumor progression in estrogen receptor-negative breast cancer. Immunopathol. Dis. Ther. 3, 117\u2013124 (2012).","journal-title":"Immunopathol. Dis. Ther."},{"key":"56928_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.tips.2011.07.001","volume":"32","author":"CH Switzer","year":"2011","unstructured":"Switzer, C. H. et al. Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer. Trends Pharm. Sci. 32, 644\u2013651 (2011).","journal-title":"Trends Pharm. Sci."},{"key":"56928_CR27","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1172\/JCI42059","volume":"120","author":"SA Glynn","year":"2010","unstructured":"Glynn, S. A. et al. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. J. Clin. Invest 120, 3843\u20133854 (2010).","journal-title":"J. Clin. Invest"},{"key":"56928_CR28","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/ijc.22336","volume":"120","author":"RL Prueitt","year":"2007","unstructured":"Prueitt, R. L. et al. Inflammation and IGF-I activate the Akt pathway in breast cancer. Int J. Cancer 120, 796\u2013805 (2007).","journal-title":"Int J. Cancer"},{"key":"56928_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/crj.12471","volume":"12","author":"PF Liu","year":"2018","unstructured":"Liu, P. F. et al. The clinical value of exhaled nitric oxide in patients with lung cancer. Clin. Respir. J. 12, 23\u201330 (2018).","journal-title":"Clin. Respir. J."},{"key":"56928_CR30","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2174\/1566524014666140724103147","volume":"14","author":"L Zhang","year":"2014","unstructured":"Zhang, L. et al. Upregulation of cytoskeleton protein and extracellular matrix protein induced by stromal-derived nitric oxide promotes lung cancer invasion and metastasis. Curr. Mol. Med. 14, 762\u2013771 (2014).","journal-title":"Curr. Mol. Med."},{"key":"56928_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6470950","volume":"2019","author":"X Gao","year":"2019","unstructured":"Gao, X. et al. Nitric oxide metabolites and lung cancer incidence: a matched case-control study nested in the ESTHER cohort. Oxid. Med. Cell Longev. 2019, 6470950 (2019).","journal-title":"Oxid. Med. Cell Longev."},{"key":"56928_CR32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/carcin\/bgp028","volume":"30","author":"KM Lee","year":"2009","unstructured":"Lee, K. M. et al. Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis 30, 621\u2013625 (2009).","journal-title":"Carcinogenesis"},{"key":"56928_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/21681805.2017.1421261","volume":"52","author":"A Erlandsson","year":"2018","unstructured":"Erlandsson, A. et al. High inducible nitric oxide synthase in prostate tumor epithelium is associated with lethal prostate cancer. Scand. J. Urol. 52, 129\u2013133 (2018).","journal-title":"Scand. J. Urol."},{"key":"56928_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2019.04.013","volume":"137","author":"JM Fahey","year":"2019","unstructured":"Fahey, J. M., Korytowski, W. & Girotti, A. W. Upstream signaling events leading to elevated production of pro-survival nitric oxide in photodynamically-challenged glioblastoma cells. Free Radic. Biol. Med 137, 37\u201345 (2019).","journal-title":"Free Radic. Biol. Med"},{"key":"56928_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/path.4545","volume":"236","author":"MA Puglisi","year":"2015","unstructured":"Puglisi, M. A. et al. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells. J. Pathol. 236, 479\u2013490 (2015).","journal-title":"J. Pathol."},{"key":"56928_CR36","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1089\/ars.2016.6850","volume":"26","author":"GA de Oliveira","year":"2017","unstructured":"de Oliveira, G. A. et al. Inducible nitric oxide synthase in the carcinogenesis of gastrointestinal cancers. Antioxid. Redox Signal 26, 1059\u20131077 (2017).","journal-title":"Antioxid. Redox Signal"},{"key":"56928_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.105592","volume":"115","author":"DA Goncalves","year":"2019","unstructured":"Goncalves, D. A. et al. Imbalance between nitric oxide and superoxide anion induced by uncoupled nitric oxide synthase contributes to human melanoma development. Int J. Biochem. Cell Biol. 115, 105592 (2019).","journal-title":"Int J. Biochem. Cell Biol."},{"key":"56928_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/modpathol.2008.128","volume":"22","author":"D Massi","year":"2009","unstructured":"Massi, D. et al. Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis. Mod. Pathol. 22, 21\u201330 (2009).","journal-title":"Mod. Pathol."},{"key":"56928_CR39","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/0008-5472.CAN-13-0588","volume":"74","author":"E Lopez-Rivera","year":"2014","unstructured":"Lopez-Rivera, E. et al. Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2. Cancer Res. 74, 1067\u20131078 (2014).","journal-title":"Cancer Res."},{"key":"56928_CR40","doi-asserted-by":"publisher","first-page":"E10127","DOI":"10.1073\/pnas.1722100115","volume":"115","author":"R Wang","year":"2018","unstructured":"Wang, R. et al. iNOS promotes CD24(+)CD133(+) liver cancer stem cell phenotype through a TACE\/ADAM17-dependent Notch signaling pathway. Proc. Natl Acad. Sci. USA 115, E10127\u2013E10136 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56928_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bbrc.2013.04.071","volume":"435","author":"YH Park","year":"2013","unstructured":"Park, Y. H. et al. iNOS promotes HBx-induced hepatocellular carcinoma via upregulation of JNK activation. Biochem. Biophys. Res. Commun. 435, 244\u2013249 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"56928_CR42","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1074\/jbc.M112.432294","volume":"288","author":"JR Hickok","year":"2013","unstructured":"Hickok, J. R., Vasudevan, D., Antholine, W. E. & Thomas, D. D. Nitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases. J. Biol. Chem. 288, 16004\u201316015 (2013).","journal-title":"J. Biol. Chem."},{"key":"56928_CR43","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1158\/0008-5472.CAN-15-1582","volume":"75","author":"D Vasudevan","year":"2015","unstructured":"Vasudevan, D. et al. Nitric oxide regulates gene expression in cancers by controlling histone posttranslational modifications. Cancer Res. 75, 5299\u20135308 (2015).","journal-title":"Cancer Res."},{"key":"56928_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102928","volume":"67","author":"HP Kuschman","year":"2023","unstructured":"Kuschman, H. P. et al. Nitric oxide inhibits FTO demethylase activity to regulate N(6)-methyladenosine mRNA methylation. Redox Biol. 67, 102928 (2023).","journal-title":"Redox Biol."},{"key":"56928_CR45","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/1873-3468.13092","volume":"592","author":"J Mauer","year":"2018","unstructured":"Mauer, J. & Jaffrey, S. R. FTO, m(6) Am, and the hypothesis of reversible epitranscriptomic mRNA modifications. FEBS Lett. 592, 2012\u20132022 (2018).","journal-title":"FEBS Lett."},{"key":"56928_CR46","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41589-019-0231-8","volume":"15","author":"J Mauer","year":"2019","unstructured":"Mauer, J. et al. FTO controls reversible m(6)Am RNA methylation during snRNA biogenesis. Nat. Chem. Biol. 15, 340\u2013347 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"56928_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/15476286.2021.2016203","volume":"19","author":"S Relier","year":"2022","unstructured":"Relier, S., Rivals, E. & David, A. The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells. RNA Biol. 19, 132\u2013142 (2022).","journal-title":"RNA Biol."},{"key":"56928_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25991-9","volume":"12","author":"DM Sapozhnikov","year":"2021","unstructured":"Sapozhnikov, D. M. & Szyf, M. Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR\/dCas9. Nat. Commun. 12, 5711 (2021).","journal-title":"Nat. Commun."},{"key":"56928_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ab.2017.06.011","volume":"534","author":"B Sudhamalla","year":"2017","unstructured":"Sudhamalla, B., Dey, D., Breski, M. & Islam, K. A rapid mass spectrometric method for the measurement of catalytic activity of ten-eleven translocation enzymes. Anal. Biochem. 534, 28\u201335 (2017).","journal-title":"Anal. Biochem."},{"key":"56928_CR50","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0076-6879(02)59174-6","volume":"359","author":"DD Thomas","year":"2002","unstructured":"Thomas, D. D. et al. Guide for the use of nitric oxide (NO) donors as probes of the chemistry of NO and related redox species in biological systems. Methods Enzymol. 359, 84\u2013105 (2002).","journal-title":"Methods Enzymol."},{"key":"56928_CR51","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.1073\/pnas.0400453101","volume":"101","author":"DD Thomas","year":"2004","unstructured":"Thomas, D. D. et al. Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc. Natl Acad. Sci. USA 101, 8894\u20138899 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56928_CR52","doi-asserted-by":"publisher","first-page":"41413","DOI":"10.1074\/jbc.M111.287052","volume":"286","author":"JR Hickok","year":"2011","unstructured":"Hickok, J. R., Sahni, S., Mikhed, Y., Bonini, M. G. & Thomas, D. D. Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable iron. J. Biol. Chem. 286, 41413\u201341424 (2011).","journal-title":"J. Biol. Chem."},{"key":"56928_CR53","doi-asserted-by":"publisher","first-page":"12896","DOI":"10.1002\/anie.201807593","volume":"57","author":"DL Wilson","year":"2018","unstructured":"Wilson, D. L., Beharry, A. A., Srivastava, A., O\u2019Connor, T. R. & Kool, E. T. Fluorescence probes for ALKBH2 allow the measurement of DNA alkylation repair and drug resistance responses. Angew. Chem. Int Ed. Engl. 57, 12896\u201312900 (2018).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"56928_CR54","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1039\/c0cs00203h","volume":"40","author":"NR Rose","year":"2011","unstructured":"Rose, N. R., McDonough, M. A., King, O. N., Kawamura, A. & Schofield, C. J. Inhibition of 2-oxoglutarate dependent oxygenases. Chem. Soc. Rev. 40, 4364\u20134397 (2011).","journal-title":"Chem. Soc. Rev."},{"key":"56928_CR55","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1021\/acs.inorgchem.6b00510","volume":"55","author":"AL Speelman","year":"2016","unstructured":"Speelman, A. L. et al. Unusual synthetic pathway for an Fe(NO)2(9) dinitrosyl iron complex (DNIC) and insight into DNIC electronic structure via nuclear resonance vibrational spectroscopy. Inorg. Chem. 55, 5485\u20135501 (2016).","journal-title":"Inorg. Chem."},{"key":"56928_CR56","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1021\/ja510393q","volume":"137","author":"JC Pereira","year":"2015","unstructured":"Pereira, J. C., Iretskii, A. V., Han, R. M. & Ford, P. C. Dinitrosyl iron complexes with cysteine. Kinetics studies of the formation and reactions of DNICs in aqueous solution. J. Am. Chem. Soc. 137, 328\u2013336 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"56928_CR57","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1039\/C5CP07266B","volume":"18","author":"J Lu","year":"2016","unstructured":"Lu, J. et al. A computational investigation on the substrate preference of ten-eleven-translocation 2 (TET2). Phys. Chem. Chem. Phys. 18, 4728\u20134738 (2016).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"56928_CR58","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.cell.2013.11.020","volume":"155","author":"L Hu","year":"2013","unstructured":"Hu, L. et al. Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation. Cell 155, 1545\u20131555 (2013).","journal-title":"Cell"},{"key":"56928_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02213-2","volume":"21","author":"R Elango","year":"2021","unstructured":"Elango, R., Vishnubalaji, R., Shaath, H. & Alajez, N. M. Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition. Cancer Cell Int. 21, 515 (2021).","journal-title":"Cancer Cell Int."},{"key":"56928_CR60","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gyorffy","year":"2021","unstructured":"Gyorffy, B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput. Struct. Biotechnol. J. 19, 4101\u20134109 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"56928_CR61","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1515\/hsz-2020-0323","volume":"402","author":"MB Palczewski","year":"2021","unstructured":"Palczewski, M. B., Kuschman, H. P., Bovee, R., Hickok, J. R. & Thomas, D. D. Vorinostat exhibits anticancer effects in triple-negative breast cancer cells by preventing nitric oxide-driven histone deacetylation. Biol. Chem. 402, 501\u2013512 (2021).","journal-title":"Biol. Chem."},{"key":"56928_CR62","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ijc.32369","volume":"145","author":"JT Fekete","year":"2019","unstructured":"Fekete, J. T. & Gyorffy, B. ROCplot.org: validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int J. Cancer 145, 3140\u20133151 (2019).","journal-title":"Int J. Cancer"},{"key":"56928_CR63","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature12433","volume":"500","author":"MJ Ziller","year":"2013","unstructured":"Ziller, M. J. et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 500, 477\u2013481 (2013).","journal-title":"Nature"},{"key":"56928_CR64","doi-asserted-by":"crossref","unstructured":"Bartha, A. & Gyorffy, B. TNMplot.com: A web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int. J. Mol. Sci. 22, 2622 (2021).","DOI":"10.3390\/ijms22052622"},{"key":"56928_CR65","doi-asserted-by":"crossref","unstructured":"Smith, C. M. & Gupta, G. P. Polymerase theta inhibition steps on the cGAS pedal. J. Clin. Investig. 133, e170660 (2023).","DOI":"10.1172\/JCI170660"},{"key":"56928_CR66","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/cjop.CJOP-D-22-00078","volume":"66","author":"X Guo","year":"2023","unstructured":"Guo, X., Bu, X., Yuan, L. & Ji, L. Collagen type V alpha 2 promotes the development of gastric cancer via M2 macrophage polarization. Chin. J. Physiol. 66, 93\u2013102 (2023).","journal-title":"Chin. J. Physiol."},{"key":"56928_CR67","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1158\/0008-5472.CAN-21-4339","volume":"82","author":"MJ Llorca-Cardenosa","year":"2022","unstructured":"Llorca-Cardenosa, M. J. et al. SMG8\/SMG9 heterodimer loss modulates SMG1 kinase to drive ATR inhibitor resistance. Cancer Res. 82, 3962\u20133973 (2022).","journal-title":"Cancer Res."},{"key":"56928_CR68","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1089\/lrb.2017.0083","volume":"17","author":"J Visser","year":"2019","unstructured":"Visser, J., van Geel, M., Cornelissen, A. J. M., van der Hulst, R. & Qiu, S. S. Breast cancer-related lymphedema and genetic predisposition: a systematic review of the literature. Lymphat Res. Biol. 17, 288\u2013293 (2019).","journal-title":"Lymphat Res. Biol."},{"key":"56928_CR69","first-page":"833","volume":"54","author":"T Handa","year":"2019","unstructured":"Handa, T. et al. Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer. Int. J. Oncol. 54, 833\u2013844 (2019).","journal-title":"Int. J. Oncol."},{"key":"56928_CR70","unstructured":"Wang, J., Luo, J., Wu, X. & Li, Z. WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer. Histol. Histopathol. 18671, 633\u2013646 (2023)."},{"key":"56928_CR71","doi-asserted-by":"publisher","first-page":"720649","DOI":"10.3389\/fcell.2021.720649","volume":"9","author":"Q Zou","year":"2021","unstructured":"Zou, Q., Lv, Y., Gan, Z., Liao, S. & Liang, Z. Identification and validation of a malignant cell subset marker-based polygenic risk score in stomach adenocarcinoma through integrated analysis of bulk and single-cell RNA Sequencing data. Front. Cell Dev. Biol. 9, 720649 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"56928_CR72","doi-asserted-by":"crossref","unstructured":"Switzer, C. H. Non-canonical nitric oxide signalling and DNA methylation: inflammation induced epigenetic alterations and potential drug targets. Br. J. Pharmacol. (2023).","DOI":"10.1111\/bph.16302"},{"key":"56928_CR73","doi-asserted-by":"publisher","first-page":"e2200022119","DOI":"10.1073\/pnas.2200022119","volume":"119","author":"CH Switzer","year":"2022","unstructured":"Switzer, C. H., Cho, H. J., Eykyn, T. R., Lavender, P. & Eaton, P. NOS2 and S-nitrosothiol signaling induces DNA hypomethylation and LINE-1 retrotransposon expression. Proc. Natl Acad. Sci. USA 119, e2200022119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56928_CR74","doi-asserted-by":"crossref","unstructured":"Signoretti, C. & Gupte, S. A. G6PD orchestrates genome-wide DNA methylation and gene expression in the vascular wall. Int. J. Mol. Sci. 24, 16727 (2023).","DOI":"10.3390\/ijms242316727"},{"key":"56928_CR75","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1172\/JCI124070","volume":"130","author":"H Takeshima","year":"2020","unstructured":"Takeshima, H. et al. TET repression and increased DNMT activity synergistically induce aberrant DNA methylation. J. Clin. Investig. 130, 5370\u20135379 (2020).","journal-title":"J. Clin. Investig."},{"key":"56928_CR76","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0014-5793(02)02520-6","volume":"517","author":"Z Zhang","year":"2002","unstructured":"Zhang, Z. et al. Crystal structure of a clavaminate synthase-Fe(II)-2-oxoglutarate-substrate-NO complex: evidence for metal centered rearrangements. FEBS Lett. 517, 7\u201312 (2002).","journal-title":"FEBS Lett."},{"key":"56928_CR77","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/42990","volume":"387","author":"PL Roach","year":"1997","unstructured":"Roach, P. L. et al. Structure of isopenicillin N synthase complexed with substrate and the mechanism of penicillin formation. Nature 387, 827\u2013830 (1997).","journal-title":"Nature"},{"key":"56928_CR78","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1101\/gad.276568.115","volume":"30","author":"KD Rasmussen","year":"2016","unstructured":"Rasmussen, K. D. & Helin, K. Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev. 30, 733\u2013750 (2016).","journal-title":"Genes Dev."},{"key":"56928_CR79","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/2643-3230.BCD-20-0173","volume":"2","author":"Y Guan","year":"2021","unstructured":"Guan, Y. et al. A therapeutic strategy for preferential targeting of TET2 mutant and TET-dioxygenase deficient cells in myeloid neoplasms. Blood Cancer Discov. 2, 146\u2013161 (2021).","journal-title":"Blood Cancer Discov."},{"key":"56928_CR80","doi-asserted-by":"publisher","first-page":"e22153","DOI":"10.1096\/fj.202101402R","volume":"36","author":"C Dusadeemeelap","year":"2022","unstructured":"Dusadeemeelap, C., Rojasawasthien, T., Matsubara, T., Kokabu, S. & Addison, W. N. Inhibition of TET-mediated DNA demethylation suppresses osteoblast differentiation. FASEB J. 36, e22153 (2022).","journal-title":"FASEB J."},{"key":"56928_CR81","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1021\/acs.jmedchem.3c01820","volume":"67","author":"R Belle","year":"2024","unstructured":"Belle, R. et al. Focused screening identifies different sensitivities of human TET oxygenases to the oncometabolite 2-hydroxyglutarate. J. Med. Chem. 67, 4525\u20134540 (2024).","journal-title":"J. Med. Chem."},{"key":"56928_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-6-r81","volume":"15","author":"EL Putiri","year":"2014","unstructured":"Putiri, E. L. et al. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells. Genome Biol. 15, R81 (2014).","journal-title":"Genome Biol."},{"key":"56928_CR83","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3892\/ol.2021.12953","volume":"22","author":"P He","year":"2021","unstructured":"He, P. et al. Effects of hypoxia on DNA hydroxymethylase Tet methylcytosine dioxygenase 2 in a KG-1 human acute myeloid leukemia cell line and its mechanism. Oncol. Lett. 22, 692 (2021).","journal-title":"Oncol. Lett."},{"key":"56928_CR84","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.celrep.2014.04.040","volume":"7","author":"CJ Mariani","year":"2014","unstructured":"Mariani, C. J. et al. TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma. Cell Rep. 7, 1343\u20131352 (2014).","journal-title":"Cell Rep."},{"key":"56928_CR85","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/stem.2621","volume":"35","author":"P Prasad","year":"2017","unstructured":"Prasad, P., Mittal, S. A., Chongtham, J., Mohanty, S. & Srivastava, T. Hypoxia-mediated epigenetic regulation of stemness in brain tumor cells. Stem Cells 35, 1468\u20131478 (2017).","journal-title":"Stem Cells"},{"key":"56928_CR86","first-page":"6457","volume":"14","author":"G Lin","year":"2017","unstructured":"Lin, G. et al. Hypoxia induces the expression of TET enzymes in HepG2 cells. Oncol. Lett. 14, 6457\u20136462 (2017).","journal-title":"Oncol. Lett."},{"key":"56928_CR87","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1158\/0008-5472.CAN-14-3208","volume":"75","author":"MZ Wu","year":"2015","unstructured":"Wu, M. Z. et al. Hypoxia drives breast tumor malignancy through a TET-TNFalpha-p38-MAPK Signaling Axis. Cancer Res. 75, 3912\u20133924 (2015).","journal-title":"Cancer Res."},{"key":"56928_CR88","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1182\/bloodadvances.2020001535","volume":"4","author":"JZ Cao","year":"2020","unstructured":"Cao, J. Z., Liu, H., Wickrema, A. & Godley, L. A. HIF-1 directly induces TET3 expression to enhance 5-hmC density and induce erythroid gene expression in hypoxia. Blood Adv. 4, 3053\u20133062 (2020).","journal-title":"Blood Adv."},{"key":"56928_CR89","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.stem.2011.01.008","volume":"8","author":"KP Koh","year":"2011","unstructured":"Koh, K. P. et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 8, 200\u2013213 (2011).","journal-title":"Cell Stem Cell"},{"key":"56928_CR90","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/nar\/gkx1197","volume":"46","author":"S Burr","year":"2018","unstructured":"Burr, S. et al. Oxygen gradients can determine epigenetic asymmetry and cellular differentiation via differential regulation of Tet activity in embryonic stem cells. Nucleic Acids Res. 46, 1210\u20131226 (2018).","journal-title":"Nucleic Acids Res."},{"key":"56928_CR91","doi-asserted-by":"publisher","first-page":"e0119837","DOI":"10.1371\/journal.pone.0119837","volume":"10","author":"G McCarty","year":"2015","unstructured":"McCarty, G. & Loeb, D. M. Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cells. PLoS One 10, e0119837 (2015).","journal-title":"PLoS One"},{"key":"56928_CR92","doi-asserted-by":"publisher","first-page":"e1002154","DOI":"10.1371\/journal.pgen.1002154","volume":"7","author":"KE Szulwach","year":"2011","unstructured":"Szulwach, K. E. et al. Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet. 7, e1002154 (2011).","journal-title":"PLoS Genet."},{"key":"56928_CR93","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","volume":"38","author":"AL Mattei","year":"2022","unstructured":"Mattei, A. L., Bailly, N. & Meissner, A. DNA methylation: a historical perspective. Trends Genet. 38, 676\u2013707 (2022).","journal-title":"Trends Genet."},{"key":"56928_CR94","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13072-018-0205-1","volume":"11","author":"D Anastasiadi","year":"2018","unstructured":"Anastasiadi, D., Esteve-Codina, A. & Piferrer, F. Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species. Epigenet. Chromatin 11, 37 (2018).","journal-title":"Epigenet. Chromatin"},{"key":"56928_CR95","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.trecan.2020.02.007","volume":"6","author":"J Smith","year":"2020","unstructured":"Smith, J., Sen, S., Weeks, R. J., Eccles, M. R. & Chatterjee, A. Promoter DNA hypermethylation and paradoxical gene activation. Trends Cancer 6, 392\u2013406 (2020).","journal-title":"Trends Cancer"},{"key":"56928_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0710-5","volume":"11","author":"EJ Rodger","year":"2019","unstructured":"Rodger, E. J., Chatterjee, A., Stockwell, P. A. & Eccles, M. R. Characterisation of DNA methylation changes in EBF3 and TBC1D16 associated with tumour progression and metastasis in multiple cancer types. Clin. Epigenet. 11, 114 (2019).","journal-title":"Clin. Epigenet."},{"key":"56928_CR97","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2217\/epi-2016-0063","volume":"8","author":"A Chatterjee","year":"2016","unstructured":"Chatterjee, A., Stockwell, P. A., Rodger, E. J., Parry, M. F. & Eccles, M. R. scan_tcga tools for integrated epigenomic and transcriptomic analysis of tumor subgroups. Epigenomics 8, 1315\u20131330 (2016).","journal-title":"Epigenomics"},{"key":"56928_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-020-0657-6","volume":"13","author":"I Rauluseviciute","year":"2020","unstructured":"Rauluseviciute, I., Drablos, F. & Rye, M. B. DNA hypermethylation associated with upregulated gene expression in prostate cancer demonstrates the diversity of epigenetic regulation. BMC Med Genomics 13, 6 (2020).","journal-title":"BMC Med Genomics"},{"key":"56928_CR99","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/ng1972","volume":"39","author":"JE Ohm","year":"2007","unstructured":"Ohm, J. E. et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39, 237\u2013242 (2007).","journal-title":"Nat. Genet."},{"key":"56928_CR100","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/sj.emboj.7600013","volume":"23","author":"V Mutskov","year":"2004","unstructured":"Mutskov, V. & Felsenfeld, G. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J. 23, 138\u2013149 (2004).","journal-title":"EMBO J."},{"key":"56928_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133896","volume":"10","author":"L Yang","year":"2015","unstructured":"Yang, L., Yu, S. J., Hong, Q., Yang, Y. & Shao, Z. M. Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer. PLoS One 10, e0133896 (2015).","journal-title":"PLoS One"},{"key":"56928_CR102","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.celrep.2012.08.030","volume":"2","author":"CH Hsu","year":"2012","unstructured":"Hsu, C. H. et al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep. 2, 568\u2013579 (2012).","journal-title":"Cell Rep."},{"key":"56928_CR103","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/onc.2012.67","volume":"32","author":"H Yang","year":"2013","unstructured":"Yang, H. et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 32, 663\u2013669 (2013).","journal-title":"Oncogene"},{"key":"56928_CR104","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10549-015-3525-x","volume":"153","author":"KW Tsai","year":"2015","unstructured":"Tsai, K. W. et al. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER\/PR-negative subtype. Breast Cancer Res. Treat. 153, 219\u2013234 (2015).","journal-title":"Breast Cancer Res. Treat."},{"key":"56928_CR105","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1541-7786.MCR-20-0359","volume":"18","author":"B Bao","year":"2020","unstructured":"Bao, B. et al. Role of TET1 and 5hmC in an obesity-linked pathway driving cancer stem cells in triple-negative breast cancer. Mol. Cancer Res 18, 1803\u20131814 (2020).","journal-title":"Mol. Cancer Res"},{"key":"56928_CR106","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/0008-5472.CAN-17-2082","volume":"78","author":"CR Good","year":"2018","unstructured":"Good, C. R. et al. TET1-mediated hypomethylation activates oncogenic signaling in triple-negative breast cancer. Cancer Res. 78, 4126\u20134137 (2018).","journal-title":"Cancer Res."},{"key":"56928_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101488","volume":"72","author":"MT Mc Auley","year":"2021","unstructured":"Mc Auley, M. T. DNA methylation in genes associated with the evolution of ageing and disease: a critical review. Ageing Res. Rev. 72, 101488 (2021).","journal-title":"Ageing Res. Rev."},{"key":"56928_CR108","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.phrs.2017.04.011","volume":"121","author":"S Socco","year":"2017","unstructured":"Socco, S., Bovee, R. C., Palczewski, M. B., Hickok, J. R. & Thomas, D. D. Epigenetics: the third pillar of nitric oxide signaling. Pharm. Res 121, 52\u201358 (2017).","journal-title":"Pharm. Res"},{"key":"56928_CR109","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-12-4081","volume":"73","author":"X Zhang","year":"2013","unstructured":"Zhang, X. et al. A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models. Cancer Res. 73, 4885\u20134897 (2013).","journal-title":"Cancer Res."},{"key":"56928_CR110","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"56928_CR111","doi-asserted-by":"crossref","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, 2 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"56928_CR112","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"56928_CR113","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"56928_CR114","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & Kaller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"key":"56928_CR115","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger, F. & Andrews, S. R. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 27, 1571\u20131572 (2011).","journal-title":"Bioinformatics"},{"key":"56928_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1664-9","volume":"20","author":"F Muller","year":"2019","unstructured":"Muller, F. et al. RnBeads 2.0: comprehensive analysis of DNA methylation data. Genome Biol. 20, 55 (2019).","journal-title":"Genome Biol."},{"key":"56928_CR117","doi-asserted-by":"publisher","first-page":"e81148","DOI":"10.1371\/journal.pone.0081148","volume":"8","author":"Q Song","year":"2013","unstructured":"Song, Q. et al. A reference methylome database and analysis pipeline to facilitate integrative and comparative epigenomics. PLoS One 8, e81148 (2013).","journal-title":"PLoS One"},{"key":"56928_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-10-r87","volume":"13","author":"A Akalin","year":"2012","unstructured":"Akalin, A. et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. 13, R87 (2012).","journal-title":"Genome Biol."},{"key":"56928_CR119","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1093\/bioinformatics\/btx183","volume":"33","author":"RG Cavalcante","year":"2017","unstructured":"Cavalcante, R. G. & Sartor, M. A. annotatr: genomic regions in context. Bioinformatics 33, 2381\u20132383 (2017).","journal-title":"Bioinformatics"},{"key":"56928_CR120","unstructured":"Frisch, M. J. et al. Gaussian 16 Rev. C.01. (Wallingford, CT, 2016)."},{"key":"56928_CR121","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1039\/b810189b","volume":"10","author":"JD Chai","year":"2008","unstructured":"Chai, J. D. & Head-Gordon, M. Long-range corrected hybrid density functionals with damped atom-atom dispersion corrections. Phys. Chem. Chem. Phys. 10, 6615\u20136620 (2008).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"56928_CR122","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1039\/C4CP04286G","volume":"17","author":"A Hellweg","year":"2015","unstructured":"Hellweg, A. & Rappoport, D. Development of new auxiliary basis functions of the Karlsruhe segmented contracted basis sets including diffuse basis functions (def2-SVPD, def2-TZVPPD, and def2-QVPPD) for RI-MP2 and RI-CC calculations. Phys. Chem. Chem. Phys. 17, 1010\u20131017 (2015).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"56928_CR123","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"56928_CR124","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D. Biol. Crystallogr. 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"56928_CR125","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D. Biol. Crystallogr. 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"56928_CR126","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0076-6879(96)68030-6","volume":"268","author":"LK Keefer","year":"1996","unstructured":"Keefer, L. K., Nims, R. W., Davies, K. M. & Wink, D. A. NONOates\u201d (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 268, 281\u2013293 (1996).","journal-title":"Methods Enzymol."},{"key":"56928_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.redox.2016.05.002","volume":"9","author":"W He","year":"2016","unstructured":"He, W. & Frost, M. C. Direct measurement of actual levels of nitric oxide (NO) in cell culture conditions using soluble NO donors. Redox Biol. 9, 1\u201314 (2016).","journal-title":"Redox Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56928-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56928-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56928-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T09:34:25Z","timestamp":1739871265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56928-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56928"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56928-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4131804\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"1 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C. is the sole inventor on patent application no. 10420838 entitled: Methods for treating cancer using iNOS-inhibitory compositions, held by Houston Methodist Hospital. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1732"}}